At the molecular level, a study shows that the Akt signalling pathway suppresses cell migration and invasion through FOXO1 to inhibit runt-related transcription factor 2 (RUNX2) transcriptional activity in prostate cancer [106]. This evidence concerns the gene AKT1 and prostate carcinoma.